Proprotein Convertase Subtilisin/Kexin Type 9 Antibodies (Pcsk9-I) Treatment Of Cardiovascular High Risk Patients In Clinical Practice. (August 2019)

Record Type:
Journal Article
Title:
Proprotein Convertase Subtilisin/Kexin Type 9 Antibodies (Pcsk9-I) Treatment Of Cardiovascular High Risk Patients In Clinical Practice. (August 2019)
Main Title:
Proprotein Convertase Subtilisin/Kexin Type 9 Antibodies (Pcsk9-I) Treatment Of Cardiovascular High Risk Patients In Clinical Practice
Authors:
Kassner, U.
Hollstein, T.
Schumann, F.
Grenkowitz, T.
Scharnagl, H.
März, W.
Steinhagen-Thiessen, E.
Abstract:
Is Part Of:
Atherosclerosis. Volume 287(2019)
Journal:
Atherosclerosis
Issue:
Volume 287(2019)
Issue Display:
Volume 287, Issue 2019 (2019)
Year:
2019
Volume:
287
Issue:
2019
Issue Sort Value:
2019-0287-2019-0000
Page Start:
e212
Page End:
Publication Date:
2019-08
Subjects:
Arteriosclerosis -- Periodicals
Electronic journals
616.136
Journal URLs:
http://www.sciencedirect.com/science/journal/00219150 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/00219150 ↗
http://www.elsevier.com/journals ↗
DOI:
10.1016/j.atherosclerosis.2019.06.645 ↗
Languages:
English
ISSNs:
0021-9150
Deposit Type:
Legaldeposit
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:
British Library DSC - 1765.874000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:
16595.xml